Image not available in RecallScope.
中新薬業 “ハイデラ and 22 other products” - Recall
Official notice
26 Nov 2021
Last checked
27 Oct 2026
An official CAA Japan notice concerns 中新薬業 “ハイデラ and 22 other products” - Recall. Manufactured using quantities of additives different from those specified in the approval documents, and other issues. Reasons for recall: (1)ハイデラ, (2)マッハII, (4)オピス錠, (5)ヅシチン錠D, (8)赤玉ベリンはら薬: Because these products were manufactured using quantities of additives different from those specified in the approval documents, we have decided to voluntarily recall all lots manufactured using those quantities. (3)新ビターコルド, (9)ニューリキスカット: Because these products were manufactured using procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (6)新かぜキノミン: Because this product was manufactured using quantities of additives different from those specified in the approval documents and additives not listed in the approval documents, we have decided to voluntarily recall all lots. (7)聖心丸, (10)せき, (11)ネツトリトンプク, (12)ノイスルピー, (13)ブレーエン, (14)解熱鎮痛アスナオール, (15)チンツーサン: Because these products were manufactured using quantities of additives different from those specified in the approval documents and procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (16)アスパライトE40, (17)アイムードE40, (18)ニューハイアートE, (19)アスパライトロイヤルE: Stability monitoring results indicate that the possibility that the measured neostigmine methylsulfate content may fall outside the approved specifications within the shelf life (4 years 6 months or 4 years 1 month) cannot be ruled out. We have therefore decided to voluntarily recall all lots with a shelf life of 4 years 6 months or 4 years 1 month. Published 2021-11-26.
What to do now
Because these products are medicines supplied through a household placement service, we know all delivery destinations. We will notify them of the recall in writing and collect the products.
Recall number
2-10439
Official notice
2021-11-26
The hazard
The hazard
Manufactured using quantities of additives different from those specified in the approval documents, and other issues. Reasons for recall: (1)ハイデラ, (2)マッハII, (4)オピス錠, (5)ヅシチン錠D, (8)赤玉ベリンはら薬: Because these products were manufactured using quantities of additives different from those specified in the approval documents, we have decided to voluntarily recall all lots manufactured using those quantities. (3)新ビターコルド, (9)ニューリキスカット: Because these products were manufactured using procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (6)新かぜキノミン: Because this product was manufactured using quantities of additives different from those specified in the approval documents and additives not listed in the approval documents, we have decided to voluntarily recall all lots. (7)聖心丸, (10)せき, (11)ネツトリトンプク, (12)ノイスルピー, (13)ブレーエン, (14)解熱鎮痛アスナオール, (15)チンツーサン: Because these products were manufactured using quantities of additives different from those specified in the approval documents and procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (16)アスパライトE40, (17)アイムードE40, (18)ニューハイアートE, (19)アスパライトロイヤルE: Stability monitoring results indicate that the possibility that the measured neostigmine methylsulfate content may fall outside the approved specifications within the shelf life (4 years 6 months or 4 years 1 month) cannot be ruled out. We have therefore decided to voluntarily recall all lots with a shelf life of 4 years 6 months or 4 years 1 month.
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Product 2
Product 3
Product 4
Product 5
Product 6
Product 7
Product 8
Product 9
Product 10
Product 11
Product 12
Product 13
Product 14
Product 15
Product 16
Product 17
Product 18
Product 19
Product 20
Product 21
Product 22
Product 23
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: 中新薬業. Contact: 中新薬業株式会社. Phone 076-475-2122.
Source & status
Source & status
Recall details
Recall details
Recall number
Event id
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.